Martin T Becker, RPH | |
1011 N Wisconsin St, Port Washington, WI 53074-1207 | |
(262) 284-3436 | |
Not Available |
Full Name | Martin T Becker |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 1011 N Wisconsin St, Port Washington, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073959748 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 8401-40 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Martin T Becker, RPH 669 W Pierre Ln, Port Washington, WI 53074-1531 Ph: (262) 284-6127 | Martin T Becker, RPH 1011 N Wisconsin St, Port Washington, WI 53074-1207 Ph: (262) 284-3436 |
News Archive
"When the G20 Ministers of Agriculture develop an action plan to address food price volatility and its impact on the poor, they should focus on both urgent actions and the vital role of smallholder farmers," Shenggen Fan, director-general of the International Food Policy Research Institute, writes in an Inter Press Service opinion piece.
"Blue Cross Blue Shield of Michigan, the University of Michigan and the Society of Hospital Medicine have selected 15 physician organizations in Michigan, including eight in Southeast Michigan, to work with 14 hospitals on a project to reduce preventable readmissions and emergency room visits. Called 'Michigan Transitions of Care Collaborative,' the project is based on a model developed by the Society of Hospital Medicine.
Researchers have discovered that specific cancer-causing genes associated with leukemias can transform mature white blood cells into leukemic cells that have all the properties of stem cells.
The sedative drugs diazepam (Valium) and lorazepam (Ativan) are equally effective in treating the prolonged seizures known as status epilepticus in children, according to a randomized, controlled study by a multi-institution team of researchers with the Pediatric Emergency Care Applied Research Network, including an expert from the Perelman School of Medicine at the University of Pennsylvania.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
› Verified 2 days ago
Mr. Brian A Weir, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1011 N Wisconsin St, Port Washington, WI 53074 Phone: 262-284-3436 |